An observational study to assess BMI, body composition, pulmonary function, resting energy expenditure and exercise capacity after ≥12 months of ivacaftor treatment
Latest Information Update: 17 Dec 2020
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 17 Dec 2020 New trial record